Cargando…

Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor

The inhibition of histone deacetylases (HDACs) holds promise as a potential anti-cancer therapy as histone and non-histone protein acetylation is frequently disrupted in cancer, leading to cancer initiation and progression. Additionally, the use of a histone deacetylase inhibitor (HDACi) such as the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drzewiecka, Małgorzata, Gajos-Michniewicz, Anna, Hoser, Grażyna, Jaśniak, Dominika, Barszczewska-Pietraszek, Gabriela, Sitarek, Przemysław, Czarny, Piotr, Piekarski, Janusz, Radek, Maciej, Czyż, Małgorzata, Skorski, Tomasz, Śliwiński, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298302/ https://www.ncbi.nlm.nih.gov/pubmed/37372475 http://dx.doi.org/10.3390/genes14061295

Ejemplares similares

Synthetic Lethality Targeting Polθ
por: Drzewiecka, Małgorzata, et al.
Publicado: (2022)

Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours
por: Barszczewska-Pietraszek, Gabriela, et al.
Publicado: (2022)

Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells
por: Drzewiecka, Małgorzata, et al.
Publicado: (2023)

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas
por: Czyż, Małgorzata, et al.
Publicado: (2016)

Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent
por: Toma, Monika, et al.
Publicado: (2018)

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
por: Hartman, Mariusz L., et al.
Publicado: (2020)

Role of miRNAs in Melanoma Metastasis
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2019)

WNT Signaling in Melanoma
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2020)

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2023)

Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality
por: Le, Bac Viet, et al.
Publicado: (2022)

MCL-1, BCL-X(L) and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
por: Hartman, Mariusz L., et al.
Publicado: (2015)

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
por: Czyz, Malgorzata, et al.
Publicado: (2019)

Pentoxifylline Inhibits WNT Signalling in β-Catenin(high) Patient-Derived Melanoma Cell Populations
por: Talar, Beata, et al.
Publicado: (2016)

Rhaponticum carthamoides transformed root extract inhibits human glioma cells viability, induces double strand DNA damage, H2A.X phosphorylation, and PARP1 cleavage
por: Skała, Ewa, et al.
Publicado: (2018)

The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder
por: Czarny, Piotr, et al.
Publicado: (2021)

Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype
por: Hartman, Mariusz L., et al.
Publicado: (2014)

Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib
por: Blasiak, Janusz, et al.
Publicado: (2015)

UV Differentially Induces Oxidative Stress, DNA Damage and Apoptosis in BCR-ABL1-Positive Cells Sensitive and Resistant to Imatinib
por: Synowiec, Ewelina, et al.
Publicado: (2015)

Doxorubicin Differentially Induces Apoptosis, Expression of Mitochondrial Apoptosis-Related Genes, and Mitochondrial Potential in BCR-ABL1-Expressing Cells Sensitive and Resistant to Imatinib
por: Synowiec, Ewelina, et al.
Publicado: (2015)

Enhanced Natural Strength: Lamiaceae Essential Oils and Nanotechnology in In Vitro and In Vivo Medical Research
por: Kowalczyk, Tomasz, et al.
Publicado: (2023)

Monoubiquitinated Fanconi Anemia D2 (FANCD2-Ub) Is Required for BCR-ABL1 Kinase -Induced Leukemogenesis
por: Koptyra, Mateusz, et al.
Publicado: (2011)

The Early Expression of HLA-DR and CD64 Myeloid Markers Is Specifically Compartmentalized in the Blood and Lungs of Patients with Septic Shock
por: Skirecki, Tomasz, et al.
Publicado: (2016)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

Orchidaceae-Derived Anticancer Agents: A Review
por: Śliwiński, Tomasz, et al.
Publicado: (2022)

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
por: Algazi, A P, et al.
Publicado: (2012)

RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
por: Toma, Monika, et al.
Publicado: (2019)

Hidden in Plants—A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies
por: Kowalczyk, Tomasz, et al.
Publicado: (2022)

PARP inhibitors: the race is on
por: Brown, Jessica S, et al.
Publicado: (2016)

The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine
por: Wigner, Paulina, et al.
Publicado: (2020)

An In Vitro Estimation of the Cytotoxicity and Genotoxicity of Root Extract from Leonurus sibiricus L. Overexpressing AtPAP1 against Different Cancer Cell Lines
por: Sitarek, Przemysław, et al.
Publicado: (2018)

Rhaponticum carthamoides Transformed Root Extract Has Potent Anticancer Activity in Human Leukemia and Lung Adenocarcinoma Cell Lines
por: Skała, Ewa, et al.
Publicado: (2018)

Transgenesis as a Tool for the Efficient Production of Selected Secondary Metabolites from Plant in Vitro Cultures
por: Kowalczyk, Tomasz, et al.
Publicado: (2020)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond †
por: Bojarska, Joanna, et al.
Publicado: (2022)

Chronic Mild Stress and Venlafaxine Treatment Were Associated with Altered Expression Level and Methylation Status of New Candidate Inflammatory Genes in PBMCs and Brain Structures of Wistar Rats
por: Bialek, Katarzyna, et al.
Publicado: (2021)

Haploinsufficiency of ZNF251 causes DNA-PKcs-dependent resistance to PARP inhibitors in BRCA1-mutated cancer cells
por: Li, Huan, et al.
Publicado: (2023)

An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines
por: Sitarek, Przemysław, et al.
Publicado: (2020)

Efficacy of PD-1 inhibitors combined with pegylated liposomal doxorubicin and dacarbazine compared with liposomal doxorubicin and dacarbazine in advanced leiomyosarcoma patients: a retrospective, single-institutional cohort study
por: Tan, Zhichao, et al.
Publicado: (2022)

Relationship between Oxidative Stress and Imatinib Resistance in Model Chronic Myeloid Leukemia Cells
por: Głowacki, Sylwester, et al.
Publicado: (2021)

Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines
por: Barciszewska, Anna-Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bc9il0nfdu35pmfb29tot6mtb5